Effect of Intraoperative Blood Loss on Perioperative Complications and Neurological Outcome in Adult Patients Undergoing Elective Brain Tumor Surgery

Vanitha Rajagopalan, Rajendra Singh Chouhan, Mihir Prakash Pandia, Ritesh Lamsal, Girija Prasad Rath, Vanitha Rajagopalan, Rajendra Singh Chouhan, Mihir Prakash Pandia, Ritesh Lamsal, Girija Prasad Rath

Abstract

Background Major blood loss during neurosurgery can lead to several complications, including life-threatening hemodynamic instabilities. Studies addressing these complications in patients undergoing intracranial tumor surgery are limited. Materials and Methods During the study period, 456 patients who underwent elective craniotomy for brain tumor excision were categorized into four groups on the basis of estimated intraoperative blood volume loss: Group A (<20%), Group B (20-50%), Group C (>50-100%), and Group D (more than estimated blood volume). The occurrence of various perioperative complications was correlated with these groups to identify if there was any association with the amount of intraoperative blood loss. Results The average blood volume loss was 11% ± 5.3% in Group A, 29.8% ± 7.9% in Group B, 68.3% ± 13.5% in Group C, and 129.1% ± 23.9% in Group D. Variables identified as risk factors for intraoperative bleeding were female gender ( p < 0.001), hypertension ( p = 0.008), tumor size >5 cm ( p < 0.001), high-grade glioma ( p = 0.004), meningioma ( p < 0.001), mass effect ( p = 0.002), midline shift ( p = 0.014), highly vascular tumors documented on preoperative imaging ( p < 0.001), extended craniotomy approach ( p = 0.002), intraoperative colloids use >1,000 mL ( p < 0.001), intraoperative brain bulge ( p = 0.03), intraoperative appearance as highly vascular tumor ( p < 0.001), and duration of surgery >300 minutes ( p < 0.001). Conclusions Knowledge of these predictors may help anesthesiologists anticipate major blood loss during brain tumor surgery and be prepared to mitigate these complications to improve patient outcome.

Keywords: blood loss; brain tumor; neurological outcome; neurosurgery; perioperative complications.

Conflict of interest statement

Conflict of Interest None declared.

Figures

Fig. 1
Fig. 1
Age-wise distribution of patients in the study groups.
Fig. 2
Fig. 2
Glasgow Outcome Scale (GOS) (1 = death, 2 = persistent vegetative state, 3 = severe disability, 4 = moderate disability, 5 = good recovery).

References

    1. Karkouti K, Wijeysundera D N, Yau T M et al.The independent association of massive blood loss with mortality in cardiac surgery. Transfusion. 2004;44(10):1453–1462.
    1. Blumberg N.Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt Transfusion 20054502(suppl)33S–39S.discussion 39S–40S
    1. Blajchman M A, Vamvakas E C. The continuing risk of transfusion-transmitted infections. N Engl J Med. 2006;355(13):1303–1305.
    1. Triulzi D J, Vanek K, Ryan D H, Blumberg N. A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion. 1992;32(06):517–524.
    1. Hill G E, Frawley W H, Griffith K E, Forestner J E, Minei J P. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma. 2003;54(05):908–914.
    1. Palomo Sanchez JC, Jimenez C, Moreno Gonzalez E et al.Effects of intraoperative blood transfusion on postoperative complications and survival after orthotopic liver transplantation. Hepatogastroenterology. 1998;45(22):1026–1033.
    1. Manning-Geist B L, Alimena S, Del Carmen M G et al.Infection, thrombosis, and oncologic outcome after interval debulking surgery: does perioperative blood transfusion matter. Gynecol Oncol. 2019;153(01):63–67.
    1. Gurusamy K S, Pissanou T, Pikhart H, Vaughan J, Burroughs A K, Davidson B R. Methods to decrease blood loss and transfusion requirements for liver transplantation. Cochrane Database Syst Rev. 2011;(12):CD009052.
    1. Lynn M, Jeroukhimov I, Klein Y, Martinowitz U. Updates in the management of severe coagulopathy in trauma patients. Intensive Care Med. 2002;28 02:S241–S247.
    1. Helling T S, Blondeau B, Wittek B J. Perioperative factors and outcome associated with massive blood loss during major liver resections. HPB (Oxford) 2004;6(03):181–185.
    1. Isbister J P, Shander A, Spahn D R, Erhard J, Farmer S L, Hofmann A. Adverse blood transfusion outcomes: establishing causation. Transfus Med Rev. 2011;25(02):89–101.
    1. Spahn D R, Shander A, Hofmann A, Berman M F. More on transfusion and adverse outcome: it’s time to change. Anesthesiology. 2011;114(02):234–236.
    1. Piastra M, Di Rocco C, Caresta E et al.Blood loss and shortterm outcome of infants undergoing brain tumour removal. J Neurooncol. 2008;90(02):191–200.
    1. Warner L L, Dowdy S C, Martin J R et al.The impact of perioperative packed red blood cell transfusion on survival in epithelial ovarian cancer. Int J Gynecol Cancer. 2013;23(09):1612–1619.
    1. Rolston J D, Han S J, Lau C Y, Berger M S, Parsa A T. Frequency and predictors of complications in neurological surgery: national trends from 2006 to 2011. J Neurosurg. 2014;120(03):736–745.
    1. Bhatnagar S, Udaya I B, Rao G S. An audit of blood transfusion in elective neurosurgery. Indian J Anaesth. 2007;51:200–204.
    1. Huber-Wagner S, Qvick M, Mussack T et al.Working Group on Polytrauma of German Trauma Society (DGU). Massive blood transfusion and outcome in 1062 polytrauma patients: a prospective study based on the Trauma Registry of the German Trauma Society. Vox Sang. 2007;92(01):69–78.
    1. Bochicchio G V, Napolitano L, Joshi M, Bochicchio K, Meyer W, Scalea T M. Outcome analysis of blood product transfusion in trauma patients: a prospective, risk-adjusted study. World J Surg. 2008;32(10):2185–2189.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться